Back to Trades
Stein Steven H
CMO & Head of Late-Stage Dev.CIK 0001673776
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 10
- Companies
- 1
- Active
- 2025–2026
Across 8 filings between 2025–2026, Stein Steven H, CMO & Head of Late-Stage Dev., has disclosed $83.8M in transactions — all concentrated in INCYTE CORP (INCY). Their disclosed trades are heavily weighted toward selling — $0 in buys and $33.2M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Nov 18 | INCY INCYTE CORP | Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | $70.3K |
| Nov 10 | INCY INCYTE CORP | Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | $28.4M |
| Jul 20 | INCY INCYTE CORP | Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | $215.3K |
| Jul 16 | INCY INCYTE CORP | Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | $3.2M |
| Jul 7 | INCY INCYTE CORP | Stein Steven H | CMO & Head of Late-Stage Dev. | Tax withheld | $254.4K |
| Jan 5 | INCY INCYTE CORP | Stein Steven H | EVP & Chief Medical Officer | Tax withheld | $1.3M |
| Jul 23 | INCY INCYTE CORP | Stein Steven H | EVP & Chief Medical Officer | Sell | $251.8K |
| Jul 16 | INCY INCYTE CORP | Stein Steven H | EVP & Chief Medical Officer | Sell | $1.0M |
8 filings